Amgen 8-K

Summary

CFO succession: Peter Griffith will retire as CFO effective 8/31/2026, and Thomas Dittrich will succeed him on 9/1/2026. Dittrich returns to Amgen after serving as CFO of Galderma and previously holding senior finance roles at Amgen. Griffith will remain an executive vice president through 1/31/2027 to support the transition.

Key Figures

• Dittrich’s annual base salary is CHF 1.07M, with a target incentive opportunity of 100% of base salary.
• FY2026 long-term incentive awards have a CHF 4.5M target value: CHF 1.35M in stock options, CHF 0.9M in restricted stock units, and CHF 2.25M in 2026–2028 performance units with goals modified for his mid-year hire.
• One-time compensation includes CHF 4.7M in restricted stock units, CHF 4.0M in cash, and a CHF 5.8M two-year retention bonus. The retention bonus is repayable pro rata if he resigns or is terminated for certain misconduct within two years of hire.
• Relocation benefits include a CHF 0.25M allowance. Severance protection for a company termination other than for cause within two years of hire is 2x salary and target bonus.